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Abstract
Objective: the role of p53 expression in odontogenic lesions has not been fully determined, but has been associated 
with cell proliferation. The purpose of this study was to analyze p53 and proliferating cell nuclear antigen (PCNA) 
expression in 4 different odontogenic lesions. Design:  expression of p53 and PCNA was analyzed in radicular and 
dentigerous cysts, odontogenic keratocysts, and calcifying odontogenic cysts (Gorlin cysts) using monoclonal antibodies 
for detection of p53 and PCNA. Results: PCNA expression was significantly greater in the basal layer of radicular 
cysts and in the suprabasal layer of odontogenic keratocysts; the percentage of p53 positive cells was significantly 
greater in the suprabasal layer of odontogenic keratocysts. Conclusions: The patterns of p53 and PCNA expression 
in dentigerous and radicular cysts were similar although the two lesions are of different origin. In odontogenic ke-
ratocysts and Gorlin cysts, results indicate a different pattern of tumor growth.
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Introduction
Of the oral lesions that affect maxillary bones, the highly 
prevalent odontogenic cysts have been the focus of several 
studies that adopted different analytic approaches. The 
interest in these lesions is high because of their similar 
radiographic and histopathologic features but different 
clinical behavior.
The p53 protein, a product of the TP53 tumor suppres-
sor gene, is expressed in the G1 phase of the cell cycle to 
allow the repair of possible damage to DNA and to arrest 
cell cycle progression to the S phase, or, alternatively, to 
induce apoptosis of cells that cannot be repaired. A low 
concentration of wild type p53 is usually found in cells 
because of its relatively short half-life, about 20 minutes. 
Its concentration increases as its half-life is extended, 
which may occur due to TP53 gene mutation, association 
of wild type p53 with other proteins, or disruption of its 
degradation pathway (1-3). 
Immunohistochemical detection of the p53 protein is of-
ten associated with TP53 gene mutations, which suggests 
that the mutant product is more stable than the wild type. 
However, the p53 clones most frequently used in immu-
nohistochemical analyses recognize both wild type and 
mutant p53. Therefore, it is unclear whether expression 
indicates gene mutation or overexpression of  the wild 
type protein due to stabilization. Overexpression of p53 
is found in lesions without TP53 gene mutation or even 
in normal tissue, as Cruz et al. (4) and Pillai et al. (5) have 
demonstrated. In these tissues, positive results are asso-
ciated with the presence of the wild type protein that, for 
some reason, is stabilized and highly concentrated, and is, 
therefore, detected by immunohistochemical methods.
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The p53 protein may accumulate in cells as a response to 
stress, which changes the balance between synthesis and 
degradation. Under normal conditions, the p53 protein 
is synthesized continuously. In the nucleus, it binds to the 
MDM2 protein, and the MDM2/p53 complex is exported 
to the cytoplasm, where it is degraded by proteosomes. This 
process keeps the cell concentration of p53 low. Protein 
concentration increases do not depend on gene activation, 
transcription and translation, but, rather, on inhibition 
of its degradation. Under stress, the ARF protein, which 
regulates MDM2, is released from the nucleolus to the 
nucleoplasm, where it binds to MDM2 or to the MDM2/
p53 complex, blocks p53 export to the cytoplasm and later 
prevents its degradation, which results in the accumulation 
of the p53 protein in the nucleus (6,7).
Rubbi and Milner (8) suggested that the nucleolus is the 
main stress sensor in the cell, and that any disruption in nu-
cleolar functions affects p53 degradation. Mammalian cells 
do not have a nucleolus during mitosis. Their full nucleolar 
functionality, in the form of a maximal level of RNAr 
synthesis, is only reached in the end of the G1 phase. This 
period of recovery of the nucleolar functionality is the time 
window when p53 levels increase during the cell cycle.
Results of immunohistochemical studies of p53 expression 
in odontogenic lesions are contradictory. A number of stu-
dies showed p53 expression in cysts (9-12) and odontogenic 
tumors (13,14), and associated these positive findings with 
the overexpression or stabilization of the wild type protein, 
which may be associated with cell proliferation. Other 
studies reported p53 positive findings in odontogenic cysts 
but not in dentigerous or radicular cysts (15), or only in 
cases of keratocysts associated with the nevoid basal cell 
carcinoma syndrome (16). Still another study found no 
p53 expression in odontogenic cysts and tumors (17) and 
assigned these findings to the absence of  mutation, to 
mutation that did not lead to protein stabilization, or to 
deletion of the TP53 gene.      
PCNA is a nuclear nonhistone protein necessary for 
DNA synthesis, and is an accessory protein for DNA 
polymerase-alpha, which is elevated during the G1/S phase 
of the cell cycle. Quiescent and senescent cells have a very 
low level of PCNA mRNA (18). PCNA expression may be 
used as a marker of cell proliferation because cells remain a 
longer time in the G1/S phase when proliferating. Also, this 
protein has an essential role in nucleic acid metabolism as 
a component of DNA replication and repair mechanism. 
An increase in PCNA levels may be induced by growth 
factors or as a result of DNA damage in the absence of 
cell cycling (19,20). 
To understand the behavior of epithelial cells in odonto-
genic cysts, this study analyzed p53 and PCNA expression 
in 4 different lesions: radicular cysts, which are inflamma-
tory lesions; dentigerous cysts, classified as development 
cysts; odontogenic keratocysts and Gorlin cysts, which 
are tumoral lesions with cystic features.
Material and Methods  
Forty-eight samples were included in the study: 11 radicular 
cysts, 12 odontogenic keratocysts; 15 dentigerous cysts, and 
10 calcifying odontogenic cysts (Gorlin cyst). All samples 
were fixed in 10% neutral buffered formalin, dehydrated in 
alcohol, cleared in xylene and embedded in paraffin. After 
that, 4-µm sections were obtained and stained with hema-
toxylin-eosin. All slides were reviewed, and the diagnosis 
was confirmed according to clinical, radiologic and histo-
pathologic features.  Two other 4-µm sections were obtained 
from each block for immunohistochemical staining. 
- Immunohistochemistry:
Immunohistochemical staining was performed at the 
Immunohistochemistry Laboratory of the Armed Forces 
Institute of  Pathology (AFIP), Washington, DC.  The 
sections were deparaffinized in xylene, rehydrated through 
graded alcohols, and immersed in 0.3% hydrogen peroxide 
in methanol to block endogenous peroxidase. Sections 
were then washed in phosphate buffered saline (PBS). 
Antigen retrieval was performed in a 20-min water bath 
(ISOTEMP 210, Fisher Scientific, USA) using a low-pH 
retrieval solution (ref. S1699, DakoCytomation, USA). 
After that, the sections were kept in the same solution for 
45 minutes to reach room temperature. Monoclonal p53 
(DO-7, 1:200, DakoCytomation, USA) and PCNA (PC-
10, 1:50 , DakoCytomation, USA) antibodies were used 
for p53 and PCNA labeling using the Autostainer Dako. 
The detection system was Envision +® (DakoCytomation, 
USA). Sections were rinsed, counterstained with Mayer 
hematoxylin, rehydrated, and cleared in xylene; slides were 
mounted in Permount (Fisher Scientific, USA). Sections 
of breast carcinoma were used as positive control, and 
omission of the primary antibody, as negative control.  
- Analysis:
For the quantitative analysis of p53 and PCNA positive 
cells, slides were examined under a Nikon optical micros-
cope, model Eclipse E2000, at 400x magnification. All 
epithelial extension was analyzed; images of selected fields 
were captured using a digital camera (Nikon Coolpix 995, 
USA) and analyzed using ImageTool for Windows 3.00 
(UTHSCSA- University of Texas Health Science Center 
in San Antonio). For the analysis of p53 and PCNA po-
sitivity, positive cells were counted in 1000 cells of each 
sample: 500 cells in the basal layer and 500 cells in the su-
prabasal layer. All brown-stained nuclei of epithelial cells 
were classified as positive regardless of staining intensity. 
Cells in the superficial layer were not counted.
The criterion used to identify cells in the suprabasal layer 
was nuclear morphology: cells immediately above the 
basal layer and with a spherical nucleus were classified as 
suprabasal; cells with flattened nuclei were classified as 
superficial and were not counted.
- Calibration and statistical analysis:
Intra-and interobserver calibrations were performed 
during the study. Kappa coefficient ranged from 0.8 to 
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1.0, and agreement was excellent. The Student t test for 
paired samples was used to compare mean percentages 
of positive cells in the different layers, and the Pearson 
coefficient was used to analyze the correlation of values 
for the two markers in each lesion. 
The study was approved by the Ethics and Research Com-
mittee of the School of Dentistry, Universidade Federal 
do Rio Grande do Sul, and by the Brazilian National 
Ethics in Research Committee (CONEP), under number 
1166/2003.
Results
PCNA and p53 expression was found in all the 48 odonto-
genic cyst samples. Mean percentages of p53 positive cells 
showed that radicular cysts had the greatest number of 
positive cells, followed by Gorlin cysts, dentigerous cysts 
and odontogenic keratocysts, both in the basal and in the 
suprabasal layers (Figure 1A,B,C,D,E,F,G,H).
However, a significant difference between layers was 
found only in keratocysts, which had greater values in 
Fig. 1. Odontogenic keratocyst lining showing prominent suprabasal p53 (A, arrows) and 
PCNA (B, arrows) expression. Epithelial cells of radicular cyst showing p53 (C, arrows) and 
PCNA (D, arrows) expression. Epithelial cells of dentigerous cyst showing p53 (E, arrow) and 
PCNA (F, arrows) expression. Note the presence of inflammatory infiltrate in the connective 
tissue. Epithelial cells of Gorlin cyst showing p53 (G, arrow) and PCNA (H, arrow) expression. 
(original magnification, X400)
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the suprabasal layer (Figure 1A). In the analysis of p53 
expression, standard deviation values were high, which 
revealed greater dispersion around the mean and suggested 
that data were heterogeneous (Table 1).
The greatest mean percentage of positive PCNA cells in 
the basal layer was found in radicular cysts, followed by 
Gorlin cysts, keratocysts and dentigerous cysts. In the 
suprabasal layer, the greatest mean percentage was found 
in keratocysts, followed by radicular cysts, Gorlin cysts, 
and dentigerous cysts. There was a significant difference 
between values in the basal and suprabasal layers of ke-
ratocysts and radicular cysts; in keratocysts, values were 
greater in the suprabasal layer (Figure 1B), whereas in 
the radicular cysts, greater values were found in the basal 
layer (Table 1). 
The correlation of mean percentages of positive p53 and 
PCNA cells in each layer revealed a direct significant co-
rrelation in the basal and suprabasal layers of dentigerous 
and Gorlin cysts, and in the basal layer of radicular cysts 
(Table 2). 
LESION LAYER N
P53+ PCNA+
Mean % SD p Mean % SD p
Radicular cyst
Basal 11 17.96 12.84
0.19
84.75 9.82
0.01*Suprabasal 11 17.67 10.23 74.25 15.31
OdontogenicKeratocyst
Basal 12 4.63 5.73
0.01*
68.25 23.59
0.01*
Suprabasal 12 9.73 4.22 83.32 20.99
Dentigerous cyst
Basal 15 8.41 10.38
0.05
60.89 31.75
0.23
Suprabasal 15 11.48 12.54 56.49 30.51
Gorlin cyst
Basal 10 14.96 16.12
0.85
71.48 33.28
     0.17
Suprabasal 10 14.38 12.38 69.50 31.02
LESION LAYER
Pearson 
correlation 
coefficient
P
Radicular cyst
Basal r = 0.829 0.01*
Suprabasal r = 0.195 0.57
Odontogenic 
Keratocyst
Basal r = 0.469 0.24
Suprabasal r = 0.435 0.16
Dentigerous cyst
Basal r = 0.756 0.01*
Suprabasal r = 0.784 0.01*
Gorlin cyst
Basal r = 0.646 0.04*
Suprabasal r = 0.777 0.01*
Discussion
Expression of p53 and PCNA was found in all lesions 
analyzed in this study. Results of studies about p53 and 
PCNA expression in odontogenic lesions are contradictory 
(9-17). According to Mighell (20), the interpretation of 
immunohistochemical studies of PCNA and p53 should 
take into consideration the complex biology of PCNA and 
p53, the effect of histologic processing, and the protocol 
used for immunohistochemical labeling. The lesion under 
study, its etiology and its clinical behavior should be taken 
into consideration because all these factors contribute to 
the accuracy of results.
Results of  cell proliferation in our study revealed that 
radicular, dentigerous and Gorlin cysts had greater mean 
percentages of  positive PCNA cells in the basal layer. 
In these 3 lesions, the basal layer was the proliferation 
compartment; in odontogenic keratocysts, the suprabasal 
layer had greater PCNA values. These unique findings 
of odontogenic keratocysts suggest that the proliferation 
compartment in these lesions is formed by the basal and 
suprabasal layers. We believe that this is a process specific 
Table 1. Comparison of mean percentages of positive p53 and PCNA cells in basal and suprabasal layers in each lesion.
* significant difference (Student t test for paired samples)
Table 2. Correlation between p53 and PCNA percentages in the basal 
and suprabasal layers in each lesion.
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to the behavior of this type of lesion, in which the cells in 
the suprabasal layer have an increased proliferative poten-
tial in comparison with healthy epithelial tissue.
Several studies about odontogenic lesions have found an 
association between p53 expression and cell proliferation 
(9, 10, 13). We believe that the association of PCNA and 
p53 expression in odontogenic lesions should be analyzed 
according to each type of lesion. The p53 protein is ex-
pressed by proliferating cells, but its accumulation in the 
cell may be caused by several factors. Cell stress is one 
of these factors since p53 is a primary mediator of cell 
response to stress.
The analysis of PCNA and p53 expression in each type of 
lesion suggests that, in radicular and dentigerous cysts, it 
may result from a response to cell stress generated by the 
inflammatory stimulus, even in those classified as develop-
ment cysts. Studies have demonstrated that growth factors 
and cytokines (interleukin 1, interleukin 6 and tumoral 
necrosis factor) are released during inflammatory events. 
Inflammatory stimuli increase cell proliferation, and infla-
mmatory cytokines may also cause cell stress (21). 
In radicular cysts, the inflammatory stimulus originates 
from the continuous aggression caused by the bacterial 
contamination of the root canal, which makes epithelial 
cells, particularly those in the basal layer, increase and 
maintain proliferation. Therefore, the high expression of 
p53 and PCNA in radicular cysts (Figure 1C,D) reflects 
both cell stress and cell proliferation caused by inflam-
matory stimuli, which may inhibit degradation of  the 
p53 protein and increase the level of PCNA even in the 
absence of cell cycling.
The initial stimulus for the formation of  dentigerous 
cysts has not been clearly identified, but an inflammatory 
infiltrate in the cystic capsule has often been described 
(22). Similarly to what happens in radicular cysts, the 
inflammatory stimulus may induce epithelial cells to ini-
tiate proliferation. Therefore, we interpret our results as 
responses to inflammatory stimuli that may be the result of 
the eruptive process, may make cells proliferate, but may be 
inconstant and present for only short periods of time. This 
may explain the lower PCNA and p53 percentages found 
in dentigerous cysts in this study Figure 1E, F). Their rate 
of proliferation is slower than that of radicular cysts, and 
the expression of markers may be more closely associated 
with cell stress caused by the inflammatory stimulus that 
led to the formation of the cyst cavity. This cavity, once 
formed, initiates a feedback process due to the physiolo-
gy of the epithelial tissue, which proliferates in the basal 
layer and desquamates into the cavity. The cyst becomes 
denser and thus attracts fluids to maintain its osmotic 
balance. Therefore, once the process initiates, it becomes 
independent of new inflammatory stimuli.
The association between inflammation and proliferation 
in odontogenic keratocysts was described by De Paula 
et al. (23), who used Ki67, PCNA and AgNOR for their 
analyses and found that cell proliferation was greater in 
cysts that had a moderate to dense inflammatory infiltrate 
than in cysts without inflammation. They reported that 
growth factors and cytokines released by the inflammatory 
infiltrate induced the increase of the number of prolifera-
ting cells, and that this increase was also associated with 
the disruption of the typical cyst structure. Kaplan and 
Hirshberg (24), however, analyzed areas with and without 
inflammation in the same lesion, compared results of fields 
in the same and in different samples, and did not find a 
significant difference. They concluded that inflammatory 
infiltrates in odontogenic keratocysts do not affect their 
proliferative potential.
Gorlin cysts had elevated values for both PCNA and p53 
expression in our study, and there was a direct significant co-
rrelation between the 2 markers in the 2 layers under analysis 
(Figure 1G,H). Neoplastic cells may have an increased proli-
ferative potential regardless of physiological conditions. The-
refore, p53 may be associated with the rate of proliferation in 
these lesions. However, Gorlin cysts are tumoral lesions, and 
the possibility of the presence of a mutant protein should 
also be taken into consideration (25,26).
In odontogenic keratocysts, now classified by the WHO as 
tumors (27), results reflected their unique characteristics. 
The inflammatory infiltrate was not a remarkable finding: 
although found in some areas, it was not always predo-
minant. The expression of markers in this type of lesion 
may indicate a cell proliferation pattern compatible with 
neoplastic cells, which is independent of inflammatory 
stimuli. Both p53 and PCNA were higher in the suprabasal 
layer, which demonstrated that this lesion has proliferation 
and maturation patterns that differ from those found in 
the other lesions studied. Such findings may explain its 
clinical behavior and its tendency to recurrence. The pre-
sence of mutant p53 in odontogenic keratocysts should 
also be taken into consideration, as demonstrated by 
Gonzáles-Moles et al. (28), who used a specific antibody 
for mutant p53. 
The results of this study show that PCNA and p53 ex-
pression in radicular and dentigerous cysts have similar 
characteristics although these two types of cyst are classi-
fied as lesions of different origin. The two tumoral lesions, 
odontogenic keratocysts and Gorlin cysts, however, did 
not share the same characteristics of marker expression, 
and results showed that their growth pattern is different. 
Further studies should be conducted to investigate the 
inflammatory characteristics of these four types of lesion, 
in particular in dentigerous cysts, to better understand the 
role of the inflammatory stimulus in their development. 
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